CXCR4 Knockdown Via CRISPR/CAS9 in a Tumor-Associated Macrophage Model Decreases Human Breast Cancer Cell Migration

• Published in: Curēus (Palo Alto, CA) CA), 2021-12, Vol.13 (12), p.e20842-e20842
• Main Authors: Jaramillo-Valverde, Luis, Levano, Kelly S, Capristano, Silvia, Tarazona, David D, Cisneros, Alberto, Yufra-Picardo, Velia M, Valdivia-Silva, Julio, Guio, Heinner
• Format: Article
• Language: English
• Subjects: Genetics; Oncology; Other
• ISSN: 2168-8184; 2168-8184
• DOI: 10.7759/cureus.20842

Introduction Breast cancer is the leading cause of cancer-related deaths in women worldwide with the majority of deaths due to metastasis. The development of metastasis is closely related to the tumor microenvironment where tumor-associated macrophages (TAMs) are the main immune cell component playing a crucial role in tumor migration. Key players in tumor progression, metastasis and survival are the receptor CXCR4 and its ligand CXCL12. CXCR4 is expressed in multiple cell types including macrophages and breast cancer cells. Many studies have focus on the role of CXCR4 expressed in breast cancer cells. Methods In this study, we investigated the role of CXCR4 expressed in TAMs on breast cancer cell migration by reducing CXCR4 expression via CRISPR-CAS9 system in differentiated THP-1 cells (a TAMs model). Results According to wound healing migration assay, MCF7 cancer cells co-cultured with genetically edited dTHP-1 cells have a lower migration rate as compared to MCF7 cancer cells co-cultured with unedited and dTHP-1 cells. Conclusion The study demonstrates the role of CXCR4 on breast cancer cell migration through TAM-cancer cell crosstalk.